Comcast Cl A (CMCSA) Shares Declined While Azimuth Capital Management Has Lowered Stake by $403,682; Armistice Capital Holds Holding in Antares Pharma (ATRS)

June 20, 2018 - By Nellie Frank

Comcast Corporation (NASDAQ:CMCSA) Logo

Armistice Capital Llc increased its stake in Antares Pharma Inc (ATRS) by 65.26% based on its latest 2018Q1 regulatory filing with the SEC. Armistice Capital Llc bought 4.96M shares as the company’s stock rose 5.65% while stock markets declined. The institutional investor held 12.56 million shares of the health care company at the end of 2018Q1, valued at $27.63 million, up from 7.60M at the end of the previous reported quarter. Armistice Capital Llc who had been investing in Antares Pharma Inc for a number of months, seems to be bullish on the $442.25 million market cap company. The stock decreased 1.74% or $0.05 during the last trading session, reaching $2.82. About 883,867 shares traded. Antares Pharma, Inc. (NASDAQ:ATRS) has declined 4.71% since June 20, 2017 and is downtrending. It has underperformed by 17.28% the S&P500. Some Historical ATRS News: 05/04/2018 – ANTARES PHARMA: FDA GRANTS XYOSTED PDUFA DATE SEPT. 29, 2018; 15/05/2018 – Perceptive Advisors LLC Exits Position in Antares Pharma; 30/05/2018 – ANTARES PHARMA GETS THIRD INSTALLMENT FROM SALE OF ZOMAJET™; 05/04/2018 – ANTARES PHARMA- ANNOUNCED FDA ACKNOWLEDGED RECEIPT OF RESUBMISSION TO CRL RECEIVED IN CONNECTION WITH XYOSTED NEW DRUG APPLICATION; 27/03/2018 – Antares Pharma Provides XYOSTED™ Regulatory Update; 05/04/2018 – Antares Pharma: Complete Response Resubmission Accepted, PDUFA Date Sept 29, 2018; 22/04/2018 – DJ Antares Pharma Inc, Inst Holders, 1Q 2018 (ATRS); 08/05/2018 – Antares Pharma at Deutsche Bank Health Care Conference Tomorrow; 05/04/2018 – ANTARES PHARMA- FDA CONSIDERED RESUBMISSION A COMPLETE, CLASS 2 RESPONSE & HAS ASSIGNED USER FEE GOAL DATE OF SEPT. 29, 2018; 27/03/2018 – Antares Capital Supports The Gores Group’s Recapitalization of TurbineAero, Inc

Azimuth Capital Management Llc decreased its stake in Comcast Corp Cl A (CMCSA) by 4.79% based on its latest 2018Q1 regulatory filing with the SEC. Azimuth Capital Management Llc sold 11,873 shares as the company’s stock declined 19.78% with the market. The institutional investor held 235,822 shares of the television services company at the end of 2018Q1, valued at $8.06 million, down from 247,695 at the end of the previous reported quarter. Azimuth Capital Management Llc who had been investing in Comcast Corp Cl A for a number of months, seems to be less bullish one the $153.65 billion market cap company. The stock increased 1.77% or $0.58 during the last trading session, reaching $33.39. About 49.66 million shares traded or 79.94% up from the average. Comcast Corporation (NASDAQ:CMCSA) has declined 21.29% since June 20, 2017 and is downtrending. It has underperformed by 33.86% the S&P500. Some Historical CMCSA News: 23/05/2018 – Comcast’s efforts to outbid Disney for 21st Century Fox assets may run into tax hurdles, according to sources; 25/04/2018 – Comcast’s Brian Roberts […]; 16/04/2018 – Digi Music News: Comcast Is Threatening Costly `Paid Prioritization’ Surcharges Against Netflix; 14/05/2018 – Comcast’s machineQ™ Lights up San Francisco Bay Area with LoRaWAN™ IoT Network; 02/04/2018 – Fidelity Select Multimedia Cuts Comcast; 23/05/2018 – Comcast Looks to Wrest Away Fox Assets From Disney (Correct); 07/05/2018 – CNBC: Comcast plans to make an all-cash bid for Fox if AT&T-Time Warner is approved; 19/04/2018 – Comcast and Independence Health to partner on new health care platform; 13/04/2018 – COMCAST TO OFFER XFINITY PACKAGES INCLUDING NETFLIX SUB; 16/05/2018 – Comcast’s Internet Essentials Program Joins Forces with Conference of Western Attorneys General to Promote Internet Safety for

Among 4 analysts covering Antares Pharma (NASDAQ:ATRS), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Antares Pharma had 14 analyst reports since March 9, 2016 according to SRatingsIntel. H.C. Wainwright maintained Antares Pharma, Inc. (NASDAQ:ATRS) on Wednesday, November 8 with “Buy” rating. H.C. Wainwright initiated the stock with “Buy” rating in Friday, September 8 report. The firm has “Buy” rating given on Thursday, February 15 by H.C. Wainwright. As per Monday, October 23, the company rating was maintained by Piper Jaffray. The stock of Antares Pharma, Inc. (NASDAQ:ATRS) earned “Buy” rating by H.C. Wainwright on Wednesday, March 14. As per Tuesday, May 8, the company rating was maintained by H.C. Wainwright. The firm earned “Buy” rating on Monday, October 23 by H.C. Wainwright. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, July 25 report. The stock of Antares Pharma, Inc. (NASDAQ:ATRS) earned “Buy” rating by Jefferies on Monday, August 7. Jefferies maintained the shares of ATRS in report on Wednesday, March 9 with “Buy” rating.

More recent Antares Pharma, Inc. (NASDAQ:ATRS) news were published by: Globenewswire.com which released: “Antares Pharma to Present at the Jefferies 2018 Healthcare Conference” on May 29, 2018. Also Seekingalpha.com published the news titled: “Antares Pharma: Excellent Risk-Reward Profile” on May 22, 2018. Nasdaq.com‘s news article titled: “Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJETâ„¢ Needle-Free Delivery System” with publication date: May 30, 2018 was also an interesting one.

Since May 9, 2018, it had 0 insider buys, and 10 insider sales for $4.58 million activity.

Investors sentiment decreased to 0.8 in 2018 Q1. Its down 0.36, from 1.16 in 2017Q4. It dropped, as 15 investors sold ATRS shares while 26 reduced holdings. 10 funds opened positions while 23 raised stakes. 55.98 million shares or 2.75% more from 54.49 million shares in 2017Q4 were reported. Geode Mgmt holds 0% of its portfolio in Antares Pharma, Inc. (NASDAQ:ATRS) for 1.30M shares. Chevy Chase Tru Holdg invested in 0% or 15,000 shares. Oppenheimer And Inc has 25,600 shares. Amer Grp Inc accumulated 91,853 shares or 0% of the stock. Moreover, Guggenheim Capital Limited Liability Company has 0% invested in Antares Pharma, Inc. (NASDAQ:ATRS). 16,659 are held by Parametric Port Associates Ltd Limited Liability Company. 9.14M were reported by Blackrock. California State Teachers Retirement Systems has invested 0% in Antares Pharma, Inc. (NASDAQ:ATRS). Manufacturers Life Ins The holds 0% or 115,943 shares. Moreover, California Pub Employees Retirement Systems has 0% invested in Antares Pharma, Inc. (NASDAQ:ATRS). Falcon Point holds 0.1% or 222,501 shares. Creative Planning accumulated 13,500 shares. Legal And General Group Inc Public Ltd Company stated it has 25,894 shares or 0% of all its holdings. Brown Advisory Limited Liability Company reported 275,000 shares stake. New York State Common Retirement Fund holds 0% in Antares Pharma, Inc. (NASDAQ:ATRS) or 141,800 shares.

Since January 26, 2018, it had 0 insider purchases, and 10 sales for $39.84 million activity. On Thursday, March 22 BLOCK ARTHUR R sold $635,776 worth of Comcast Corporation (NASDAQ:CMCSA) or 18,839 shares. WATSON DAVID N also sold $4.84 million worth of Comcast Corporation (NASDAQ:CMCSA) shares. ROBERTS BRIAN L sold $25.24M worth of stock. BURKE STEPHEN B sold 190,756 shares worth $8.11M.

Among 33 analysts covering Comcast Corporation (NASDAQ:CMCSA), 24 have Buy rating, 1 Sell and 8 Hold. Therefore 73% are positive. Comcast Corporation had 86 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by Wells Fargo on Thursday, January 25 with “Outperform”. The firm has “Buy” rating by Oppenheimer given on Monday, August 14. As per Thursday, August 3, the company rating was upgraded by Guggenheim. The company was maintained on Thursday, October 26 by SunTrust. Bank of America maintained it with “Buy” rating and $54 target in Thursday, January 25 report. As per Thursday, January 18, the company rating was downgraded by Instinet. The stock has “Buy” rating by Wells Fargo on Monday, October 23. Pivotal Research maintained the shares of CMCSA in report on Thursday, December 17 with “Buy” rating. The firm has “Buy” rating by Oppenheimer given on Thursday, July 27. As per Friday, July 7, the company rating was maintained by RBC Capital Markets.

Azimuth Capital Management Llc, which manages about $1.36 billion US Long portfolio, upped its stake in Facebook Inc (NASDAQ:FB) by 5,465 shares to 74,847 shares, valued at $11.96M in 2018Q1, according to the filing. It also increased its holding in Old by 1,762 shares in the quarter, for a total of 36,217 shares, and has risen its stake in Ishares Msci Eafe (EFA).

More notable recent Comcast Corporation (NASDAQ:CMCSA) news were published by: Seekingalpha.com which released: “Comcast Goes Fox Hunting And Shoots Itself” on June 20, 2018, also Marketwatch.com with their article: “Nasdaq notches record; Dow extends losing streak to 7 days” published on June 20, 2018, Nasdaq.com published: “Confidently Rush into Comcast Corporation — Fears Are Overblown” on June 14, 2018. More interesting news about Comcast Corporation (NASDAQ:CMCSA) were released by: Fool.com and their article: “Comcast vs. Disney: Expect a Grudge Match Bidding War for Fox Media” published on June 19, 2018 as well as Seekingalpha.com‘s news article titled: “Hulu CEO on Netflix content spending” with publication date: June 20, 2018.

Analysts await Comcast Corporation (NASDAQ:CMCSA) to report earnings on July, 26. They expect $0.61 earnings per share, up 17.31% or $0.09 from last year’s $0.52 per share. CMCSA’s profit will be $2.81 billion for 13.68 P/E if the $0.61 EPS becomes a reality. After $0.62 actual earnings per share reported by Comcast Corporation for the previous quarter, Wall Street now forecasts -1.61% negative EPS growth.

Antares Pharma, Inc. (NASDAQ:ATRS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>